"Genomics of schizophrenia and pharmacogenomics of antipsychotic drugs"
written by Ramón Cacabelos, Pablo Cacabelos, Gjumrakch Aliev,
published by Open Journal of Psychiatry, Vol.3 No.1, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Population-level pharmacogenomics for precision drug development in dementia
Expert Review of Precision Medicine and Drug Development, 2018
[2] Pharmacogenetics in Psychiatry
Advances in Pharmacology, 2018
[3] Association of genetic variants in CYP2D6, ABCB1 genes and non-genetic factors with clinical response to risperidone in Thai schizophrenic patients
Thesis, 2016
[4] The role of glucuronidation in drug resistance
Pharmacology & Therapeutics, 2016
[5] Evaluation of gas chromatography mass spectrometry and pattern recognition for the identification of bladder cancer from urine headspace
Analytical Methods, 2016
[6] Neuroimmune crosstalk in CNS disorders: the histamine connection
Current Pharmaceutical Design, 2016
[7] Cytogenetics and Selected Biochemical Phenotypes in Indian Schizophhrenic Patients
[8] Pharmacogenomics of Antidepressant Drugs
Melatonin, Neuroprotective Agents and Antidepressant Therapy, 2016
[9] Pharmacogenomics of antidepressants
[10] Зависимость результатов лекарственной терапии от генетического полиморфизма ряда кандидатных генов при параноидной шизофрении
[11] Perform a meta-analysis for the variant MTHFR rs1801131 in chronic allograft nephropathy
[12] Impact of Genomic Medicine on the Future of Neuropsychopharmacology
[13] Pharmacogenetics of Neurodegenerative Disorders
Preventive and Predictive Genetics: Towards Personalised Medicine, 2015
[14] Pharmacogenetics and Antipsychotic Treatment Response/Фармакогенетски Тестирања И Одговор Кон Третман Со Антипсихотоци
prilozi, 2015
[15] Epigenomic Networking in Drug Development: From Pathogenic Mechanisms to Pharmacogenomics
Drug development research, 2014